Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingjiu Yang

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
FEBS Letters|March 16, 2017
Smurf1 controls S phase progression and tumorigenesis through Wee1 degradationRongfei Wei, Jing Guo, Mengyuan Li, et al.
Cancer Gene Therapy|June 23, 2021
Inhibition of host Ogr1 enhances effector CD8<sup>+</sup> T-cell function by modulating acidic microenvironmentLin Cao, Weisha Li, Xingjiu Yang, et al.
Animal Models and Experimental Medicine|January 17, 2020
Downregulation of HNRNPK in human cancer cells inhibits lung metastasisMengyuan Li, Wenlong Zhang, Xingjiu Yang, et al.
Cancer Gene Therapy|October 5, 2021
Correction: Inhibition of host Ogr1 enhances effector CD8<sup>+</sup> T-cell function by modulating acidic microenvironmentLin Cao, Weisha Li, Xingjiu Yang, et al.
Oncotarget|December 22, 2017
HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathwayHao Huang, Yong Han, Xingjiu Yang, et al.
Animal Models and Experimental Medicine|June 28, 2021
Novel spontaneous myelodysplastic syndrome mouse modelWeisha Li, Lin Cao, Mengyuan Li, et al.
Oncology Letters|November 16, 2020
Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinomaHongfei Liu, Xiaohong Chen, Xingjiu Yang, et al.
Nanoscale|February 23, 2022
Real-time <i>in vivo</i> imaging reveals specific nanoparticle target binding in a syngeneic glioma mouse modelWenlong Zhang, Xiangyu Chen, Dong Ding, et al.
Animal Models and Experimental Medicine|June 5, 2023
Anti-apoptotic protein BCL-XL as a therapeutic vulnerability in gastric cancerYumin Wei, Liping Zhang, Chao Wang, et al.
Cellular Signalling|December 5, 2024
AIM2 promotes the progression of HNSCC via STAT1 mediated transcription and IL-17/MAPK signalingDong Ding, Hongfei Liu, Liping Zhang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
FEBS Letters|March 16, 2017
Smurf1 controls S phase progression and tumorigenesis through Wee1 degradationRongfei Wei, Jing Guo, Mengyuan Li, et al.
Cancer Gene Therapy|June 23, 2021
Inhibition of host Ogr1 enhances effector CD8<sup>+</sup> T-cell function by modulating acidic microenvironmentLin Cao, Weisha Li, Xingjiu Yang, et al.
Animal Models and Experimental Medicine|January 17, 2020
Downregulation of HNRNPK in human cancer cells inhibits lung metastasisMengyuan Li, Wenlong Zhang, Xingjiu Yang, et al.
Cancer Gene Therapy|October 5, 2021
Correction: Inhibition of host Ogr1 enhances effector CD8<sup>+</sup> T-cell function by modulating acidic microenvironmentLin Cao, Weisha Li, Xingjiu Yang, et al.
Oncotarget|December 22, 2017
HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathwayHao Huang, Yong Han, Xingjiu Yang, et al.
Animal Models and Experimental Medicine|June 28, 2021
Novel spontaneous myelodysplastic syndrome mouse modelWeisha Li, Lin Cao, Mengyuan Li, et al.
Oncology Letters|November 16, 2020
Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinomaHongfei Liu, Xiaohong Chen, Xingjiu Yang, et al.
Nanoscale|February 23, 2022
Real-time <i>in vivo</i> imaging reveals specific nanoparticle target binding in a syngeneic glioma mouse modelWenlong Zhang, Xiangyu Chen, Dong Ding, et al.
Animal Models and Experimental Medicine|June 5, 2023
Anti-apoptotic protein BCL-XL as a therapeutic vulnerability in gastric cancerYumin Wei, Liping Zhang, Chao Wang, et al.
Cellular Signalling|December 5, 2024
AIM2 promotes the progression of HNSCC via STAT1 mediated transcription and IL-17/MAPK signalingDong Ding, Hongfei Liu, Liping Zhang, et al.
Pageof 2